• 한국축산식품학회지
• /
• 제31권3호
• /
• pp.442-450
• /
• 2011

본 연구는 mouse와 rat에 대한 발효유의 급여에 의한 장 기능 개선과 변비 예방 효과 및 변비 치료 효과를 알아보고자 수행하였다. 동물실험을 통하여 발효유의 투여 농도에 따라 유의적인 차이를 확인할 수 있었으며, 소화관 이 실험에서는 중농도와 고농도 투여에서 유의적인 수준으로 이동률의 증가가 관찰되었고, 변비 예방 및 치료 효과에 대한 실험에서는 변비 유발 물질인 loperamide 단독 투여군에 비하여 발효유를 함께 투여한 결과, 변의 개수는 고농도 투여에 의하여 유의적인 증가가 관찰되었고, 분변량과 변의 수분함량은 중농도와 고농도 투여군에서 유의적인 증가가 관찰되었다. 이상의 동물 실험 결과를 통하여, 기능성 발효유의 반복적인 투여는 변비 예방과 변비 치료에 효과가 있는 것으로 확인되었다.

• 한국의학물리학회지:의학물리
• /
• 제24권3호
• /
• pp.171-175
• /
• 2013

본 연구에서는 한국원자력연구원(KAERI)에서 하나로(HANARO) 원자로를 통하여 새로이 개발한 근접치료용 Ir-192 선원의 기기적 안정성과 기존에 사용되는 근접치료기와의 호환성을 평가하기 위한 팬톰을 개발하고 임상기기 적합성 평가를 실험하였다. 다양한 근접치료용 어플리케이터와 선원의 적합성 결과는 일정한 비율의 곡률의 변화에 대해서는 반경 2.2~2.7 cm 범위에서 정상작동 하였고 급격한 힘의 변화를 고려한 경우에서는 반경 1.5~1.8 cm 범위에서 정상작동 할 수 있음을 확인하였다. 어플리케이터의 모양변화에 따른 선원의 머무름 시간 오차의 평가에서는 선원이 도달 가능한 점까지 에서는 거의 변화가 없어 보였다. 근접방사선치료를 위해 사용되어지는 방사선 선원은 그 크기가 작고 종양의 다양한 모양과 위치에 안정적으로 도달될 수 있어야 한다. 이와 같은 기기적 안정성을 평가하기 위해 본 연구에서 설계 고안된 기기적 안정성 평가 팬톰은 선원의 굴곡의 최적 조건을 평가하는데 유효하다고 생각되며, 한국원자력연구원에서 개발된 근접치료용 Ir-192 선원의 기기적 안정성시험결과 기존의 사용되어지는 수입산 선원과 차이가 없음을 확인할 수 있었다.

• The Korean Journal of Pain
• /
• 제9권1호
• /
• pp.151-158
• /
• 1996

Background: Buprenorphine, a new synthetic thebaine derivative, is a partial agonist of the opioid $\mu$-receptor with high receptor affinity, great lipid solubility, and slow rate of opiate receptor association and dissociation. Continuous epidural infusion of opioid can possibly produced undesirable effects, such as respiratory depression, pruritus, etc, in spite of effective postoperative analgesia. Methods: The present study was undertaken to compare the analgesic properties and side effects of continuous epidural infusion of buprenorphine combined with bupivacaine, and morphine combined with bupivacaine in 90 patients following elective gynecologic lower abdominal surgery. At the end of surgery, the initial bolus doses were 3 mg morphine (M group), 0.15 mg buprenorphine (0.15B group), 0.3 mg buprenorphine (0.3B group) combined with 0.25% bupivacaine 10ml, and subsequent continuous infusion doses were 6 mg morphine plus 0.125% bupivacine 100 ml (M group) and 0.6mg buprenorphine plus 0.125% bupivacaine 100 ml (0.15B, 0.3B, group) during 48 hours. The assessment of analgesic efficacy and side effects were made at arrival of recovery room, 1 hr, 4 hr, 8 hr, 24 hr, 36 hr, and 48 hr after the epidural injection. Results: The pain score during 48 hours was significantly higher in the 0.15B group than in the M group and 0.3B group (P<0.05), and the number of patients requiring additional analgesics was significantly higher in the 0.15B group than in the M group and 0.3B group (P<0.05). Signs of respiratory depression were not noted, and the incidence of pruritus, nausea, and vomiting was slightly lower in the 0.15B group and 0.3B group than in the M group, and the incidence of sedation and urinary retention was similar in three group. The subjective rating of satisfaction was better in the 0.3B group than in the M group and 0.15B group (P<0.05). Conclusion: The above results suggest that continuous epidural infusion of buprenorphine combined with low-dose bupivacaine is an advisable method of postoperative analgesia.

• 농약과학회지
• /
• 제3권1호
• /
• pp.1-12
• /
• 1999

유망한 신규 합성 제초제 후보화합물 KSC-13906의 제초 활성과 특성을 온실 시험과 야외 폿트 및 포장 시험을 통하여 조사한 결과, KSC의 살초 스펙트럼은 넓어 사마귀풀과 밭뚝외풀을 제외한 7초종(피, 올챙이고랭이, 물달개비, 너도방동사니, 올미, 올방개, 가래, 벗풀)에 대하여 $2.5{\sim}5$ g ai/ha의 처리량에서도 90% 이상 방제하였다. 또한 기존의 sulfonylurea계 제초제들과는 달리 특이적으로 3엽기까지의 피에 대한 방제효과가 우수하였다. 벼에 대한 약해시험 결과 직파벼 3엽기 이후, 벼 이앙 10일 이후 처리하는 것이 바람직하였다. 야외 폿트 시험결과 $3{\sim}5$ g ai/ha로 5 DAT에 처리하였을 때 발생초종을 완전히 방제하였으며, 포장시험에서는 3 g ai/ha의 KSC-13906을 이앙 후 5, 10, 15일에 처리하여도 잡초방제효과는 모두 90% 이상으로 우수하였다. 특히 피에 대한 방제효과는 100%로 나타났으며, 대조약제 PYR의 21 g ai/ha와 유사한 잡초방제효과를 나타내었다. 다년생 잡초중에서 올방개에 대한 살초효과는 처리시기에 관계없이 탁월하였다. KSC-13906을 직파벼에 사용하고자 할 경우에는 제제형태를 변화시키거나 약해경감제를 사용하여 직파벼에 대한 안전성을 제고시키지 않으면 안될 것으로 판단되었다. 신규 시험화합물 KSC-13906의 직파벼에 대한 약해를 제거시킬 수 있다면 처리 폭이 넓은 강력한 신규 논제초제로 개발될 수 있을 것으로 생각된다.

• 생명과학회지
• /
• 제24권4호
• /
• pp.377-385
• /
• 2014

본 연구는 남해특화작목인 섬애약쑥의 활용도를 높이고 건강식품 소재로서의 가능성을 제시하기 위하여 음건한 섬애약쑥과 일정기간 발효시킨 섬애약쑥의 이화학적 성분을 비교하고, 물과 에탄올 추출물(30%, 50%, 70%, 100%)을 제조하여 항산화 활성과 tyrosinase 및 xanthine oxidase 저해 활성을 측정하였다. 수율은 섬애약쑥 30% 에탄올 추출물에서 29.74%로 가장 높았으나 총 페놀 및 플라보노이드 함량은 섬애약쑥 70% 에탄올 추출물에서 각각 72.25 mg/g 및 33.34 mg/g으로 가장 높았다. 항산화 활성을 측정한 결과 모든 추출물에서 농도가 증가함에 따라 그 활성이 증가하였으며, 특히 섬애약쑥 70% 에탄올 추출물은 DPPH, ABTS 라디칼 소거능 및 ${\beta}$-carotene linoleic 탈색 방지 효과가 가장 우수하였다. Tyrosinase 저해 활성은 $500{\mu}g/ml$ 농도에서 섬애약쑥 70% 에탄올 추출물이 50.01%로 가장 높았으나 100% 에탄올 추출물은 11.44%로 가장 낮았다. Xanthine oxidase 저해 활성은 $250{\mu}g/ml$ 농도에서 섬애약쑥 물 추출물이 60% 이상으로 가장 높았다. 이상의 결과를 종합하여 볼 때, 섬애약쑥은 발효하지 않았을 때 항산화 활성이 더 우수하였으며, 70% 에탄올로 추출할 경우 가장 항산화 효과가 높았다. 또한, 섬애약쑥 추출물은 tyrosinase 및 xanthine oxidase 저해에도 상당한 효과를 가지며, 이러한 결과는 페놀 및 플라보노이드 함량과 상관관계가 높은 것으로 판단된다.

• 한국수정란이식학회지
• /
• 제27권3호
• /
• pp.141-147
• /
• 2012

This study was operated to establish induction using ultrasonography by estimating the relation of follicle size and estrus manifestation. Clinical estrus symptoms were observed 97.4% in cows and 87.5% in heifers when overall 55 cows were induced to estrus in a single dose of $PGF_{2{\alpha}}$ after verifying CL through ultrasonography, which means estrus hours among those 52 cows showing the clinical estrus symptoms were estimated 2.39 days on cows and for 2.37 days on heifers which showed no differences (p>0.05). The estrus manifestation hours according to the follicle size in cows didn't have any significance each other (p>0.05), though estrus hours was 54 hours (the shortest) with follicle size bigger than 10 mm and were made up within 69 hours. The estrus manifestation hours according to the follicle size in heifers didn't have any significance each other (p>0.05) and took around 42 hours (the shortest) with follicle size of 5mm (the smallest) and were made up within 66 hours. Follicles after $PGF_{2{\alpha}}$ injection were ovulated and assigned to many phases as follows; Group 1 (growing phase) - continuously growing into ovulation, Group 2 (growing and static phase) - delaying in growth after the growth of follicles, Group 3 (static and growing phase) - growing after growth delay, Group 4 (regressing and new growing phase) - the follicle is closed and a new follicle grows. In addition, the process of follicle development and estrus hours had no significance each other (p>0.05), though estrus manifestation hours in Group 1 and 2 was relatively short, and in Group 3 and 4 for a relatively long time. In the result of all above, the estrus manifestation hours after $PGF_{2{\alpha}}$ injection has no differences accoring to the follicle size in cows and heifers. Therefore, High pregnancy rate is obtained when practicing artificial insemination within 3 days in estrus or TAI in 72 to 80 hours after adminitrating $PGF_{2{\alpha}}$.

• Journal of Pharmaceutical Investigation
• /
• 제40권2호
• /
• pp.125-131
• /
• 2010

A bioequivalence study of LANIDIEM$^{(R)}$ tablet 4 mg (Samil. Co., Ltd.) to Vaxar$^{(R)}$ tablet 4 mg (GlaxoSmithKline Co., Ltd.) was conducted according to the guidelines of Korea Food and Drug Administration (KFDA). Forty healthy male Korean volunteers were enrolled in the study and thirty six volunteers completed the study according to the protocol. Thirty six volunteers received each medicine at the lacidipine dose of 4 mg in a $2{\times}2$ crossover study. There was one week wash-out period between the doses. Plasma concentrations of lacidipine were monitored by a high performance liquid chromatography - tandem mass spectrometry (LC-MS/MS) for over a period of 24 hours after drug administration. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 24 hr) was calculated by the linear trapezoidal rule method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were compiled from the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_t$ and $C_{max}$. No significant sequence effect was found for all of the bioavailability parameters indicating that the crossover design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for LANIDIEM$^{(R)}$/Vaxar$^{(R)}$ were log 0.8102~log 1.0417 and log 0.8493~log 1.1439, respectively. These values were within the acceptable bioequivalence intervals of log 0.80~log 1.25. Thus, our study demonstrated the bioequivalence of LANIDIEM$^{(R)}$ tablet 4 mg and Vaxar$^{(R)}$ tablet 4 mg with respect to the rate and extent of absorption.

• 대한두경부종양학회지
• /
• 제10권2호
• /
• pp.218-224
• /
• 1994

Soft tissue sarcoma of the head and neck is not frequent neoplasm, accounting for less than 1% of all malignant neoplasm in the region. The histological varieties include osteogenic sarcoma, malignant fibrous histiocytoma, rhabdomyosarcoma, fibrosarcoma, tenosynovial sarcoma, angiosarcoma and chondrosarcoma. Rhabdomyosarcomas of the head and neck usually occur in children under the age of 10 years (over 70%) and rarely develop in adults over the age of 20 years. The prevalent sites of involvement include the orbit, nasal cavity, external ear, paranasal sinus and soft tissue of mouth and the primary location of tumor is considered to be one of the important prognostic factors. Before the 1960s, when surgical resection was the only method of treatment, the 5-year survival rate was less than 20%, but recently it has been greatly improved by the multimodality treatment, combining surgery with chemotherapy and radiation therapy. Here we treated a rhabdomyosarcoma woman with three cycles of high dose chemotherapy followed by radiation therapy. After the, completion of preoperative treatments, successful result of more than partial response was achieved. Three months later total maxillectomy and radical neck dissection was performed. There was no evidence of tumor infiltration in the resected tumor and regional lymphnodes but metastasized tumor cells in cervical lymphnodes were detected. Tumor cell infiltration was also found on the bone marrow biopsy to evaluate the pancytopenia which occurred during postoperative recovery. Two months later she died of secondary bone marrow failure. We think that this multimodality treatment combining pre-operative chemotherapy, radiotherapy and surgery might play an important role in curative resection and eyeball preservation in patients with rhabdomyosarcoma involving the eyeball.

• Radiation Oncology Journal
• /
• 제37권1호
• /
• pp.37-42
• /
• 2019

Purpose: To identify prognostic factors influencing progression-free survival (PFS) of aggressive fibromatosis (AF) after postoperative radiotherapy (PORT) and assess correlations between immunohistochemistry (IHC) features of β-catenin/smooth muscle actin (SMA) and PFS. Materials and Methods: Records of 37 patients with AF treated by PORT from 1984 to 2015 were retrospectively reviewed. Fifteen patients underwent wide excision for AF and 22 patients received debulking operation. The median total dose of PORT was 59.4 Gy. IHC staining results of β-catenin and SMA were available for 11 and 12 patients, respectively. Results: The median follow-up duration was 105.9 months. Five-year PFS rate was 70.9%. Tumor size or margin status was not related to PFS in univariate analysis (p = 0.197 and p = 0.716, respectively). Multivariate analysis showed that increased interval from surgery to PORT (>5.7 weeks) was a marginal risk factor for PFS (p = 0.054). Administration of PORT at the initial diagnosis resulted in significantly improved PFS compared to deferring PORT after recurrence (p = 0.045). Patient with both risk factors of deferring PORT after recurrence and interval from surgery to PORT >5.7 weeks had significantly lower 5-year PFS than patients without risk factor (34.1% vs. 100.0%; p = 0.012). Nuclear β-catenin intensity tended to inversely correlate with 5-year PFS, although it did not reach statistical significance (62.5% at low vs. 100.0% at high; p = 0.260). SMA intensity was not related to PFS (p = 0.700). Conclusion: PORT should be performed immediately after surgery irrespective of margin status or tumor size especially in recurrent case. Nuclear β-catenin staining intensity of IHC might correlate with local recurrence.

• 생명과학회지
• /
• 제18권1호
• /
• pp.9-15
• /
• 2008

마늘의 주성분인 유황 함유 화합물을 이용하여 사람 low density lipoprotein (LDL)의 산화에 대하여 항산화 활성을 실험하였다. 유황함유화합물인 1-methyl-1-cysteine, dimethyl trisulfide 및 1-vinyl-4H-1,3-dithiin의 농도를 각각 40, 60, $80{\mu}g/ml$ 씩 첨가하여 $Cu^{2+}$ 및 macrophages 유도로 LDL을 산화할 때 항산화 효능을 TBARS로 측정한 결과 용량 의존형으로 나타났으며 유황 함유 화합물이 모두 효능이 있었으며 항산화력은 2-vinyl-4H-1,3-dithiin > 1-methyl-1-cysteine > methyl trisulfide 순이었다. 이 때 유황 함유 화합물의 LDL에 대한 공액 2중결합에 대한 항산화 실험에서도 항산화 효과가 있었으며 $60{\mu}g/ml$의 농도에서 거의 억제되었다. 유황 함유 화합물 중에서는 2-vinyl-4H-1,3-dithiin이 다른 유황 함유 화합물에 비하여 약간 높은 항산화 효능을 나타내었다. Endothelial cell을 이용한 LDL의 산화에 대한 억제율은 2-vinyl-4H-1,3-dithiin이 가장 높게 나타났다.